| |
| | NEJM -- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and ... |
 | | Steven M. Haffner, M.D., Seppo Lehto, M.D., Tapani Rönnemaa, M.D., Kalevi Pyörälä, M.D., and Markku Laakso, M.D. Full Text |
 | | Markku Laakso, M.D. Background Type 2 (non-insulin-dependent) diabetes is associated |
 | | Lautamaki, R., Airaksinen, K.E. J., Seppanen, M., Toikka, J., Luotolahti, M., Ball, E., Borra, R., Harkonen, R., Iozzo, P., Stewart, M., Knuuti, J., Nuutila, P. Rosiglitazone Improves Myocardial Glucose Uptake in Patients With Type 2 Diabetes and Coronary Artery Disease: A 16-Week Randomized, Double-Blind, Placebo-Controlled Study. |
| content.nejm.org /cgi/content/abstract/339/4/229 (2927 words) |
|